Multiple Sclerosis Clinical Trial
Official title:
The Effect of Telerehabilitation Based Motor Imagery Training on Gait and Balance Performance of the Persons With Multiple Sclerosis: A Randomized Controlled Trial
Verified date | March 2018 |
Source | Dokuz Eylul University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Motor imagery training facilitates the neural plasticity with increasing the neuronal
cortical pathways in the brain. Motor imagery training is an effective way in stroke
survivors. However, its effects in persons with multiple sclerosis (MS) are not known.
Additionally, telerehabilitation based motor imagery training is very rare treatment way
which requires more research. Therefore, this study aims to investigate the effect of
telerehabilitation based motor imagery training on gait and balance performance of the
persons with MS.
The participants will be allocated into three groups, including motor imagery training,
wait-list control group, and healthy control group.
All the assessments will be performed before and after the training in the 8-week motor
imagery training group. The participants in the control group will underwent the assessment
with a 8-week interval. The healthy participants will be assessed only one.
The motor imagery training will be designed for the individual basis with following standard
protocols. It will be applied two times a week for 8 weeks. The first one and/or two sessions
will be performed in the clinic, the other will be performed at the patients' home with a
video-conference telerehabilitation technique.
Status | Completed |
Enrollment | 70 |
Est. completion date | November 2017 |
Est. primary completion date | October 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of multiple sclerosis - Having the Expanded Disability Status Scale 0 - 4.0 - Relapse-free period at the last 3 months - Enough computer use ability - Having computer and internet connection Exclusion Criteria: - Having severe musculoskeletal, cardiovascular, pulmonary, or metabolic disease - Severe cognitive impairment - Pregnancy |
Country | Name | City | State |
---|---|---|---|
Turkey | Dokuz Eylul University Hospital, MS Outpatient Clinic | Izmir | |
Turkey | Dokuz Eylul University, School of Physical Therapy and Rehabilitation | Izmir |
Lead Sponsor | Collaborator |
---|---|
Dokuz Eylul University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dynamic Gait Index | Change from Baseline at 8 weeks | ||
Secondary | Expanded Disability Status Scale | At Baseline | ||
Secondary | Kinesthetic and Visual Imagery Questionnaire (KVIQ)-10 | Change from Baseline at 8 weeks | ||
Secondary | Movement Imagery Questionnaire—Revised Second Edition (MIQ-RS) | Change from Baseline at 8 weeks | ||
Secondary | Mental Chronometry for 2-Meter Walk Test | Change from Baseline at 8 weeks | ||
Secondary | Mental Chronometry for 5-Meter Walk Test | Change from Baseline at 8 weeks | ||
Secondary | Mental Chronometry for 10-Meter Walk Test | Change from Baseline at 8 weeks | ||
Secondary | Mental Chronometry for Timed 25-Foot Walk | Change from Baseline at 8 weeks | ||
Secondary | Mental Chronometry for Timed Up and Go Test | Change from Baseline at 8 weeks | ||
Secondary | Mental Chronometry for Five Times Sit to Stand Test | Change from Baseline at 8 weeks | ||
Secondary | 2-Meter Walk Test | Change from Baseline at 8 weeks | ||
Secondary | 5-Meter Walk Test | Change from Baseline at 8 weeks | ||
Secondary | 10-Meter Walk Test | Change from Baseline at 8 weeks | ||
Secondary | Timed 25-Foot Walk | Change from Baseline at 8 weeks | ||
Secondary | 2-Minute Walk Test | Change from Baseline at 8 weeks | ||
Secondary | Twelve Item MS Walking Scale | Change from Baseline at 8 weeks | ||
Secondary | Timed Up and Go Test | Change from Baseline at 8 weeks | ||
Secondary | Five Times Sit to Stand Test | Change from Baseline at 8 weeks | ||
Secondary | Curl-up Test | Change from Baseline at 8 weeks | ||
Secondary | Activities-specific Balance Confidence Scale | Change from Baseline at 8 weeks | ||
Secondary | Postural Stability Test by Balance System™ | Change from Baseline at 8 weeks | ||
Secondary | The Limits of Stability Test by Balance System™ | Change from Baseline at 8 weeks | ||
Secondary | Fall Risk Test by Balance System™ | Change from Baseline at 8 weeks | ||
Secondary | Modified Fatigue Impact Scale | Change from Baseline at 8 weeks | ||
Secondary | Hospital Anxiety and Depression Scale | Change from Baseline at 8 weeks | ||
Secondary | Multiple Sclerosis International Quality of Life Questionnaire | Change from Baseline at 8 weeks | ||
Secondary | Symbol Digit Modalities Test | Change from Baseline at 8 weeks | ||
Secondary | Selective Reminding Test | Change from Baseline at 8 weeks | ||
Secondary | 10/36 Spatial Recall Test | Change from Baseline at 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|